(8 Jan 2025) Siren has closed a $9.5M funding round, led by Mölnlycke Health Care (who invested $8M in the […]
Mölnlycke’s Lead Role in Siren’s $9.5M Round: A Strategic Shift Read Post »
Earlier this week, Diligence Wound Care Global’s Managing Director Rafael Mazuz visited Morgan Stanley’s Global HQ in NYC to spend
The MedTech Moment: Wound Care Expert Insights Read Post »
Upcoming Wound Care and Related Conferences, Meetings, Exhibitions, & Industry Events There used to be a couple of solid online
Upcoming Wound Care Conferences & Events Read Post »
Coloplast’s announcement is the latest large and significant advanced wound care (AWC) industry deal. As the high level details have
Coloplast’s acquisition of Kerecis: Considerations and implications Read Post »
Advanced Wound Care Global, our vehicle for bringing advanced wound care to areas of the world where the need and
Yesterday (29 Jul 2021), Bioventus and Misonix jointly announced an M&A. This deal is particularly significant in the advanced wound
Bioventus-Misonix M&A: AWC Continues “Bleed” Into Adjacencies Read Post »
Today (6 Jan 2021), Henry Schein, a top global medical, dental, and veterinary solutions provider / distributor with a global
Henry Schein Acquires Majority Stake in Prism Medical Products Read Post »
Advanced wound care’s position in the evolving COVID-19 landscape Global economies have been slammed by COVID-19 in the first part
COVID-19: Preliminary Operational and Commercial Wound Care Insights Read Post »
Despite the overwhelming majority of R&D, regulatory, sales, marketing, and corporate finance focus in the advanced wound care (AWC) sector
Underappreciated Advanced Wound Care Opportunities in 2020 and Beyond Read Post »
The European Wound Management Association (EWMA) conference in Gothenburg, Sweden earlier this month was a great success. We witnessed several
At the recent Symposium on Advanced Wound Care (SAWC Spring 2019), there were several interesting developments and companies to watch
What happened? Smith & Nephew (NYSE: SNN) will be acquiring Osiris Therapeutics (NASDAQ: OSIR) for $660M. The investment, announced today,
Perspectives on Smith & Nephew’s Announced Acquisition of Osiris Therapeutics Today Read Post »
The Association for The Advancement of Wound Care (AAWC) has just wrapped up its pressure ulcer summit in Atlanta, Georgia.
We are frequently tapped by analysts, fund managers, investment banks, and other financial and investment professionals–from small independent funds through
Investing in Advanced Wound Care? Avoid These 3 Costly Mistakes Read Post »
What We’ve Been up to in 2018 Q3 – Q4 and What It Means for the Global Wound Care Business
